Pichia pastoris strain capable of stably expressing recombinant collagen and application of pichia pastoris strain
By knocking out the YPS1 gene in Pichia saccharomyces strain, optimizing the recombinant collagen-encoded gene and using CRISPR/Cas9 editing, the problem of instability in recombinant collagen expression in Pichia saccharomyces strain was solved, and higher expression volume and purity were achieved , simplifies the production process.
Patent Information
- Application Number
- CN202411448471.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-16
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-10-16
AI Technical Summary
The existing Pichia saccharomyces strains used for recombinant collagen expression in collagen expression have problems such as easy degradation and instability of fermentation products in actual production, resulting in instability in expression and low purity.
By modifying the Pichia cerevisia strain, knocking out the secreted protein degradation enzyme-related gene YPS1, optimizing the recombinant collagen-encoding gene, and using CRISPR/Cas9 gene editing method to construct the YPS1 gene editing vector to improve the expression and stability of exogenous proteins .
The expression amount and stability of recombinant collagen is significantly improved, the purity is higher, and there is no significant impact on the growth rate of the host, simplifying the purification process and shortening the cycle.
Smart Images

Figure CN119081906A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of genetic engineering, and specifically relates to a Pichia yeast strain capable of stably expressing recombinant collagen and an application thereof. Background Art
[0002] Collagen is a biopolymer, the main component of animal connective tissue, and the most abundant and widely distributed functional protein in mammals. Collagen is an important bioactive material and is widely used in cosmetics, medicine and other fields.
[0003] In the prior art, collagen is obtained from animal tissue extraction and microbial fermentation. Compared with natural collagen, collagen from microbial fermentation overcomes the potential virus risks of traditional extraction methods. Currently, host bacteria used for fermentation include Escherichia coli, yeast, etc.
[0004] However, the Pichia pastoris strain currently used for expressing recombinant type III collagen has been found to have problems such as easy degradation and instability of the fermentation product, namely, recombinant type III collagen, during actual production. Therefore, it is urgent to provide a recombinant yeast strain that can express collagen more stably and with higher activity. Summary of the invention
[0005] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a Pichia pastoris strain that can stably express recombinant collagen and its application. The present invention transforms the Pichia pastoris strain to express the recombinant collagen encoding gene, and further optimizes and knocks out its secretory protein degradation enzyme related genes, so that the recombinant type III collagen expressed by the mutant is more stable and has higher purity. The present invention provides a research basis and a new approach to improve the expression amount and stability of recombinant collagen in Pichia pastoris.
[0006] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:
[0007] In a first aspect, the present invention provides a Pichia pastoris strain capable of stably expressing recombinant collagen. The strain uses a Pichia pastoris strain as a starting strain, expresses a recombinant collagen encoding gene, and knocks out the gene YPS1 of the secretory protein degrading enzyme in the Pichia pastoris.
[0008] The present invention constructs a recombinant yeast strain with more stable collagen expression and higher activity, providing a research basis and a new approach for improving the expression and stability of recombinant collagen in Pichia pastoris.
[0009] Among them, YPS1 is a gene encoding the protease YAP3, and the action site of YAP3 is located at the C-terminus of a single or paired basic amino acid. Since such sites are extremely common in protein polypeptides, most exogenous proteins are degraded by the protease YAP3 when expressed in yeast cells. In the present invention, knocking out the YPS1 gene can significantly increase the expression level of the exogenous protein, and does not significantly affect the growth rate of the host.
[0010] Preferably, the Pichia pastoris strain is Pichia pastoris strain GS115.
[0011] The present invention uses Pichia pastoris strain GS115 as the starting strain, and GS115 is a histidine-deficient strain (His-), which is suitable for screening expression vectors with his4 gene.
[0012] Preferably, the recombinant collagen encoding gene includes that shown in SEQ ID NO.1.
[0013] In the present invention, the coding gene of the recombinant collagen is optimized, and the optimized sequence is more suitable for expression in Pichia pastoris strains.
[0014] Preferably, the recombinant collagen encoding gene is expressed in the form of plasmid or chromosomal integration.
[0015] Preferably, the plasmid includes pPIC9K, pGAPZa or pPICZa, etc.
[0016] The pPIC9K vector of the present invention contains an alpha factor secretion signal peptide sequence, which can secrete and express exogenous protein genes; the pPIC9K vector also contains the promoter and transcription terminator of the alcohol oxidase-1 (AOX1) gene, which can be induced by methanol, making the extraction and purification process of the recombinant protein simpler and more convenient.
[0017] Preferably, the method for knocking out the gene YPS1 of secretory protein degrading enzyme in Pichia pastoris comprises:
[0018] The CRISPR / Cas9 gene editing method was used to construct a YPS1 gene editing vector targeting the target sequence of the YPS1 gene. The YPS1 gene editing vector was transformed into a Pichia pastoris expression strain containing a recombinant collagen encoding gene to knock out the YPS1 gene in the strain.
[0019] Preferably, the YPS1 gene editing vector includes: gRNA and hsCas9.
[0020] Preferably, the site targeted by the gRNA is the YPS1 gene; the DNA sequence corresponding to the gRNA includes those shown in SEQ ID NO.3 and SEQ ID NO.4.
[0021] In the present invention, the gRNA knockout effect is very good, can cause frameshift mutation of the target gene, and has a good targeting effect.
[0022] In a second aspect, the present invention provides a YPS1 gene editing vector, which includes: gRNA and hsCas9; the site targeted by the gRNA is the YPS1 gene; the DNA sequence corresponding to the gRNA includes those shown in SEQ ID NO.3 and SEQ ID NO.4.
[0023] In a third aspect, the present invention provides a vector for expressing recombinant collagen, wherein the vector includes a gene encoding the recombinant collagen.
[0024] In a fourth aspect, the present invention provides a method for stably expressing recombinant collagen, the method comprising:
[0025] The Pichia pastoris strain capable of stably expressing recombinant collagen described in the first aspect is used for fermentation, and the fermentation product is purified by a four-step hydrophobic chromatography method to obtain pure collagen.
[0026] Preferably, the four-step purification by hydrophobic chromatography comprises the following steps:
[0027] (1) Equilibration: flush the column with the equilibration solution at a linear flow rate until the pH, UV, and Cond detection baselines are stable and consistent with the equilibration buffer;
[0028] (2) Sampling: Loading the sample and collecting the flow-through components during the loading process; after the loading is completed, flushing with equilibrium buffer to wash out the unbound materials until the UV detection value drops to the initial value;
[0029] (3) Washing: Use elution buffer and equilibration buffer to wash and remove impurities with weak binding force;
[0030] (4) Elution: Use elution buffer and equilibration buffer to elute the target protein and collect the eluted fractions.
[0031] Preferably, in step (1), the equilibrium solution comprises, by concentration, 19-20 mM PB, 0.9-1 M ammonium sulfate, and pH 7.9-8.0. 19-20 mM PB may be, for example, 19 mM, 19.5 mM or 20 mM, etc.; 0.9-1 M ammonium sulfate may be, for example, 0.9 M, 0.95 M or 1 M, etc.; pH 7.9-8.0 may be, for example, 7.9 or 8.0, etc.
[0032] Preferably, in step (1), the linear flow rate is 20-30 mL / min, for example, 20 mL / min, 23 mL / min, 25 mL / min, 27 mL / min, 29 mL / min or 30 mL / min, and the amount of the equilibrium solution is 2.5-3.5 times the column volume, for example, 2.5, 2.7, 2.9, 3.0, 3.1, 3.3 or 3.5, etc.
[0033] Preferably, in step (2), the sample loading amount is 1.25-1.5 times the column volume, for example, it can be 1.25, 1.3, 1.35, 1.4, 1.45 or 1.5, etc.; the loading flow rate is 20-30 mL / min, for example, it can be 20 mL / min, 22 mL / min, 24 mL / min, 25 mL / min, 26 mL / min, 28 mL / min or 30 mL / min, etc.
[0034] In a specific embodiment, the 1.25-1.5 times column volume is 500-600 mL.
[0035] Preferably, in step (2), the sample loaded is a mixture of equal volumes of fermentation broth supernatant and equilibration buffer.
[0036] Preferably, in step (2), the flushing flow rate is 20-30 mL / min, for example, it can be 20 mL / min, 22 mL / min, 24 mL / min, 25 mL / min, 26 mL / min, 28 mL / min or 30 mL / min, and the amount of the equilibration buffer is 2-3 times the column volume, for example, it can be 2, 2.5 or 3, etc.
[0037] Preferably, in step (3), the volume ratio of the elution buffer to the equilibration buffer is (3-3.5):(6.5-7), for example, it can be 3:6.5, 3:7, 3.5:6.5 or 3.5:7, etc.
[0038] Preferably, the elution buffer comprises, by concentration, 19-20 mM PB, such as 19 mM, 19.5 mM or 20 mM, etc., and pH 7.9-8.0, such as 7.9 or 8.0, etc.
[0039] Preferably, in step (3), the flow rate of the washing is 20-30 mL / min, for example, it can be 20 mL / min, 22 mL / min, 24 mL / min, 25 mL / min, 26 mL / min, 28 mL / min or 30 mL / min.
[0040] Preferably, in step (4), the volume ratio of the elution buffer to the equilibration buffer is (6-6.5):(3.5-4), for example, it can be 6:3.5, 6:4, 6.5:3.5 or 6.5:4, etc.
[0041] Preferably, in step (4), the elution flow rate is 20-30 mL / min, for example, it can be 20 mL / min, 22 mL / min, 24 mL / min, 25 mL / min, 26 mL / min, 28 mL / min or 30 mL / min.
[0042] In the present invention, the sample pre-treatment is added to the above four-step purification method, and the sample and the balancing solution are mixed by using the premixer of the purifier, thereby improving the stability of the target protein; the washing and elution processes are simplified, and the washing and elution can be successfully performed using a small amount of balancing solution and elution solution.
[0043] In the present invention, after eluting the protein, the chromatography column is further rinsed and stored. The chromatography column is washed with at least 2 column volumes of 1-1.2M NaOH at a speed of 15-20mL / min to remove residual contaminants in the packed column, such as lipids, endotoxins, nucleic acids, etc. The chromatography column is then washed with 5-10CV of distilled water at a speed of 15-20mL / min until the pH of the effluent is neutral and Cond is close to 0 to remove NaOH. Finally, it is washed and stored with at least 3CV of 20% ethanol to prevent microbial growth.
[0044] In a fifth aspect, the present invention provides the use of the Pichia pastoris strain capable of stably expressing recombinant collagen described in the first aspect, the YPS1 gene editing vector described in the second aspect, the vector expressing recombinant collagen described in the third aspect, or the method capable of stably expressing recombinant collagen described in the fourth aspect in the preparation of recombinant collagen.
[0045] The numerical range described in the present invention not only includes the point values listed above, but also includes any point values between the above numerical ranges that are not listed. Due to space limitations and for the sake of simplicity, the present invention no longer exhaustively lists the specific point values included in the range.
[0046] Compared with the prior art, the present invention has the following beneficial effects:
[0047] The present invention constructs a strain with significantly improved recombinant collagen production and stability; and optimizes the hydrophobic chromatography purification process, thereby simplifying the process, shortening the cycle, and improving the recovery rate of collagen. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] Figure 1 This is the identification result of Yps1-1 transformants.
[0049] Figure 2 This is the identification result of Yps1-2 transformants.
[0050] Figure 3 It is a schematic diagram of the recombinant plasmid.
[0051] Figure 4 It is the growth curve of different transformants.
[0052] Figure 5 It is the result of electrophoresis detection of fermentation broth supernatant.
[0053] Figure 6 This is a chromatography diagram of the starting strain GS115-Col.
[0054] Figure 7 This is a chromatographic process diagram of the mutant GS115-Col-yps1-1.
[0055] Figure 8 This is a chromatographic process diagram of the mutant GS115-Col-yps1-2.
[0056] Fig. 9 This is the BCA protein quantitative detection result in Example 1.
[0057] Fig.10 This is the BCA protein quantitative detection result of COL2 in Comparative Example 1. DETAILED DESCRIPTION
[0058] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.
[0059] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0060] Example 1
[0061] 1. Design gRNA sequence
[0062] The YPS1 gene encoding Pichia pastoris GS115 aspartic protease was searched in the NCBI database. According to its nucleotide sequence, the corresponding gRNA sequence was designed using the CHOPCHOP (https: / / chopchop.cbu.uib.no / ) website to obtain the corresponding gRNA expression cassettes.
[0063] The DNA sequence of the YPS1 gene is shown in SEQ ID NO.2.
[0064] The gRNA targeting the YPS1 gene, the DNA sequence corresponding to the gRNA includes SEQ ID NO.3 and SEQ ID NO.4:
[0065] SEQ ID NO. 3: AGTTTGTGCTCGGTGATACCTT.
[0066] SEQ ID NO. 4: TATTCAATTTTGGGGGTGCCTAC.
[0067] 2. Construction of recombinant plasmid vector
[0068] Suzhou Biotechnology Co., Ltd. was commissioned to synthesize and construct the recombinant vector: pPpT4_pHTX1-PARS1-YPS1-gRNA-hsCas9. The Pichia pastoris gene editing plasmid vector pPpT4_pHTX1-PARS1-hsCas9 was digested with NotI and then connected to the two gRNA expression cassette clones of the YPS1 gene to obtain pPpT4_pHTX1-PARS1-YPS1-1-gRNA-hsCas9 and pPpT4_pHTX1-PARS1-YPS1-2-gRNA-hsCas9.
[0069] 3. Transfection of the recombinant plasmid into Pichia pastoris strain GS115-Col
[0070] The hsCas9 and gRNA on the pPpT4_pHTX1-PARS1-gRNA-hsCas9 plasmid vector are used to coordinately target and cut the yeast genome, and then repaired by non-homologous end joining. It is easy to obtain a knockout mutant of the corresponding gene with a simple transformation screening. The simplified method for preparing Pichia pastoris electroporation competent cells and electroporation transformation of Pichia pastoris electroporation competent cells is based on the method of (Lin-Cereghino J, 2005). The specific steps include:
[0071] (1) Streak the competent Pichia yeast on a YPD plate and culture it in a 30°C incubator for two days.
[0072] (2) Pick a healthy single colony and place it in YPD liquid medium, and culture it in a shaking incubator at 30°C overnight.
[0073] (3) Transfer an appropriate amount of overnight culture solution to a 1L Erlenmeyer flask containing 100mL of liquid YPD to control the initial OD 600 The concentration was 0.15-0.2 and cultured in a shaking incubator at 30°C.
[0074] (4) To OD 600 The cells were collected by centrifugation at 500 g for 5 min at room temperature.
[0075] (5) Resuspend the cells with 9 mL of ice-cold BEDS solution, add 1 mL of 1 M DTT solution dropwise, and incubate at 30°C on a shaker (100 rpm) for 5 min.
[0076] (6) Collect the cells by centrifugation at 500 g for 5 min at room temperature and resuspend the cells in 2 mL of ice-cold BEDS.
[0077] (7) Aliquot the resuspended cells into pre-cooled 1.5 mL centrifuge tubes, 50 μL per tube, and quickly store the prepared competent cells in a -80°C refrigerator.
[0078] (8) Mix 100 ng of circular or 2 μg of linear plasmid DNA with 50 μL of competent cells and incubate the mixture on ice for 2 min.
[0079] (9) Pipette the mixture of competent cells and plasmid into a 2 mm pre-cooled electroporation cup on ice, wipe off the water on the cup body, and then place it in the groove of the electroporator and pulse at 1.5 kV for 5.0 s.
[0080] (10) Immediately add 1 mL of a 1:1 mixture of YPD and 1 M sorbitol, pipette the cells evenly in the electroporator, then aspirate the solution and place in a 1.5 mL sterile centrifuge tube. Incubate at 30 °C on a shaker for 1 h, and then coat the plates with MD or YPD (with a final concentration of 100 μg / mL Zeocin added).
[0081] 4. Screening and identification of transformants
[0082] The plates were placed in a 30°C incubator for 3 days, and single colonies grew on all plates. Ten single colonies were picked from each transformed plate and cultured in a liquid YPD medium containing a final concentration of 100 μg / mL Zeocin for 16 hours, and then an appropriate amount of bacterial liquid was taken to extract its genomic DNA, and the nucleotide sequence near the gene mutation site was sequenced. Finally, the Cas9 plasmid in the successfully identified strain was eliminated by subculturing in a non-resistant YPD medium, and a Pichia strain without Zeocin resistance was screened. Since the pPpT4_pHTX1-PARS1-hsCas9 plasmid carries a Pichia autonomous replication sequence (PARS1), the PARS1 sequence is easily lost under non-resistant conditions. Therefore, after the correct knockout strain is screened, it only needs to be subcultured in a medium without antibiotic resistance to obtain a knockout mutant strain with CRISPR / Cas9 plasmid elimination.
[0083] Pichia pastoris genome extraction reference Method of Fungal DNA Mini Kit (OMEGA):
[0084] (1) Place 10-50 mg of yeast cells in a 2 mL centrifuge tube, add 600 μL of CSPL buffer, and vortex vigorously.
[0085] (2) Incubate in a 65°C water bath for 30 min. During the incubation process, invert the centrifuge tube several times to ensure that the sample is fully mixed.
[0086] (3) Add 600 μL of chloroform:isoamyl alcohol (24:1), vortex vigorously, and centrifuge at 12,000 rpm for 10 min.
[0087] (4) Carefully pipette 300 μL of the top layer of supernatant into a new 1.5 mL centrifuge tube.
[0088] (5) Add 150 μL of CXD buffer and 300 μL of anhydrous ethanol to the centrifuge tube and vortex evenly.
[0089] (6) Add all the vortexed solution including the precipitate to the collection tube. DNAMini column, centrifuge at 12000rpm for 1min.
[0090] (7) Discard the supernatant, add 650 μL DNA elution buffer (Wash Buffer), and centrifuge at 12000 rpm for 1 min.
[0091] (8) Repeat step 7 to wash the adsorbed DNA again.
[0092] (9) Centrifuge the empty adsorption column at maximum speed for 2 min.
[0093] (10) Transfer the DNAMini Column to a clean 1.5mL centrifuge tube.
[0094] (11) Add 100 μL of elution buffer or deionized water heated to 65°C and centrifuge at maximum speed for 1 min.
[0095] (12) Pipette the collected solution containing genomic DNA into the DNA Mini Column and centrifuge at the highest speed for 1 min.
[0096] (13) The obtained genomic DNA was stored at -20°C for future use.
[0097] PCR detection was performed using detection primers, and the PCR reaction conditions were: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s, annealing at 63°C for 30 s, extension at 72°C for 2 min, 35 cycles; extension at 72°C for 5 min; the PCR products were sequenced by Beijing Qingke Biotechnology Co., Ltd., and the sequencing results were compared with the original genome sequence to screen for the correct knockout mutants.
[0098] Detection sequence of upstream primer: 5'-GCTTTGATAGCGAGCGTACC. (SEQ ID NO.5)
[0099] Detection of the sequence of the downstream primer: 3'-CTGCTTCTTCCTCCCTCGAG. (SEQ ID NO.6)
[0100] The results of transformant sequencing are as follows Figure 1 and Figure 2 As shown, Figure 1 This is the identification result of Yps1-1 transformant. Figure 2 This is the identification result of Yps1-2 transformants.
[0101] 5. Comparison of the original strain and the recombinant strain, including expression, yield, and stability
[0102] The secretory expression vector pPIC9K of the starting strain contains the alpha factor secretion signal peptide sequence, which can secrete and express foreign protein genes; the vector also contains the promoter and transcription terminator of the alcohol oxidase-1 (AOX1) gene, which are separated by a multiple cloning site (MCS), and the coding sequence of the recombinant collagen is inserted into it. Figure 3 shown.
[0103] The alpha factor secretion signal peptide sequence is shown in SEQ ID NO. 7. The sequence of the promoter of the alcohol oxidase-1 (AOX1) gene, the coding sequence of the recombinant collagen, and the transcription terminator is shown in SEQ ID NO. 8. The sequence of the expression vector pPIC9K (empty vector) is shown in SEQ ID NO. 9.
[0104] The secretory expression of recombinant collagen is controlled by the AOX1 promoter and can be induced by methanol. The secretory expression method is as follows:
[0105] Prepare YPD, BMGY and BMMY culture media respectively.
[0106] BMGY medium: 1% yeast extract, 2% peptone, 1.34% YNB, 1% glycerol and 10% 1 M PBS (pH=6.0).
[0107] BMMY medium: 1% yeast extract, 2% peptone, 1.34% YNB, 1% methanol and 10% 1 M PBS (pH=6.0).
[0108] YPD solid medium: 1% yeast extract, 2% peptone, 2% glucose and 2% agar powder.
[0109] First, the recombinant collagen expression strain was streaked on YPD solid culture medium, placed in a 30°C incubator for 20-24 hours to activate the strain; a single colony was picked up and placed in 10mL BMGY culture medium, and placed in a 30°C shaker for 24 hours; the OD value of the bacterial solution was detected, and an appropriate amount of the bacterial solution was centrifuged at a speed of 5000rpm for 5min, and the bacteria were resuspended with BMMY and washed repeatedly; the washed bacteria were transferred to 50mL BMMY culture medium, and 1% methanol was added, and the bacteria were cultured in a 30°C shaker for 5 days to start fermentation, and 1% methanol was added every 24 hours; the fermentation liquid was centrifuged at high speed, and the supernatant was taken for electrophoresis detection; and then purified by hydrophobic chromatography and other methods to obtain pure recombinant collagen.
[0110] Detection of bacterial OD during fermentation in BMGY medium 600 , draw a growth curve ( Figure 4 ), and found no significant difference in growth rate between the knockout mutant and the starting strain.
[0111] Electrophoresis was used to detect the protein expression in the supernatant of each fermentation broth ( Figure 5 ), and the results showed that the content of target protein in the two knockout mutants was significantly greater than that in the starting strain.
[0112] 6. Comparison of recombinant collagen yield after hydrophobic chromatography purification
[0113] The knockout mutant and the original strain were fermented with 600 mL each, and then the supernatant was centrifuged and purified by hydrophobic chromatography. The purification process was as follows:
[0114] Sample: Recombinant collagen fermentation broth supernatant
[0115] Hydrophobic chromatography column: PrePack 50×200-Phenyl Purose 6FF, purchased from Qianchun Biotechnology Co., Ltd.
[0116] Protein Purification Instruments from Saipu Biotech Co., Ltd.
[0117] Experimental materials: distilled water;
[0118] Fermentation broth sample: 300 mL of fermentation broth supernatant.
[0119] Equilibration buffer: 20 mM PB, 1 M ammonium sulfate, pH 8.0.
[0120] Elution buffer: 20 mM PB, pH 8.0.
[0121] Wash buffer: 1M NaOH.
[0122] The above solution must be filtered through a 0.45μm filter.
[0123] 7. Experimental steps:
[0124] (1) The column was flushed with equilibration buffer at a linear flow rate of 30 mL / min for 3 CV (3 column volumes, 1 CV = 400 mL) until the pH, UV, and Cond detection baselines were stable and consistent with the equilibration buffer.
[0125] (2) The sample and equilibration buffer were loaded at a rate of 20 mL / min in a 1:1 ratio, and the flow-through fractions during the loading process were collected and the purity and content of the target protein were detected.
[0126] (3) After loading, rinse with equilibration buffer at a rate of 30 mL / min for 2 CV to wash out unbound materials until the UV detection value drops to the initial value.
[0127] (4) Wash with elution buffer and equilibration buffer at a ratio of 3:7 for 2CV at a rate of 30 mL / min to remove impurities with weak binding affinity.
[0128] (5) Elution buffer and equilibration buffer were added at a ratio of 6:4 for 2CV at a rate of 30 mL / min to elute the target protein, and the eluted fractions were collected.
[0129] (6) Wash the column with at least 2 column volumes of 1 M NaOH at a rate of 20 mL / min to remove residual contaminants in the packed column, such as lipids, endotoxins, nucleic acids, etc.
[0130] (7) Wash the column with 5-10 CV of distilled water at a rate of 20 mL / min until the pH of the effluent is neutral and the Cond is close to 0 to remove 1 M NaOH.
[0131] (8) Wash and store with 3 CV of 20% ethanol to prevent microbial growth.
[0132] Figure 6 This is the chromatographic process diagram of the starting strain GS115-Col; Figure 7 is the chromatographic process diagram of mutant GS115-Col-yps1-1; Figure 8 This is the chromatographic process diagram of mutant GS115-Col-yps1-2.
[0133] Chromatography process diagram: Most of the recombinant collagen was eluted by 60% elution buffer and 40% equilibrium buffer. Among them, the elution peak area of the recombinant protein obtained by fermentation of the mutant was significantly larger than that of the starting strain, indicating that the recombinant collagen yield of the mutant was significantly higher than that of the starting strain.
[0134] 8. Hydrophobic chromatography sample electrophoresis detection
[0135] The electrophoresis results are shown in Figure 5 The electrophoresis results showed that the target protein band of the mutant was significantly denser than that of the starting strain, indicating that the target protein yield of the mutant was higher than that of the starting strain.
[0136] 9. Comparison of sample concentration after hydrophobic chromatography purification
[0137] After chromatography, the protein concentrations of the eluted fractions of each sample were compared, and each protein sample was quantified according to the operating instructions of the BCA protein quantification kit, and statistical analysis was performed using Prism7 software.
[0138] Fig. 9 This is the result of BCA protein quantitative detection. The results show that the content of recombinant collagen produced by the mutant fermentation is significantly higher than that of the starting strain, indicating that the knockout of the YPS1 gene significantly improved the stability of the recombinant collagen produced by secretory expression.
[0139] The plasmid vector used for knockout is shown in SEQ ID NO. 10. The recombinant collagen encoding gene is shown in SEQ ID NO.1.
[0140] Comparative Example 1
[0141] This example provides a method for preparing recombinant collagen. The difference between the method and the method in Example 1 is that the expressed recombinant collagen encoding gene COL2 is as shown in SEQ ID NO.11.
[0142] The BCA method was used to detect the final target protein content before and after protein YPS1 knockout. The target protein content statistical chart is shown in Fig.10 ,from Fig.10 It can be seen that the content of recombinant collagen produced by the mutant fermentation is not much different from that of the starting strain, and the yield of the above protein is lower than the yield of the protein shown in SEQ ID NO.1 in the present application, indicating that the Pichia pastoris strain stably expressing recombinant collagen constructed in the present application has a better expression effect.
[0143] Comparative Example 2
[0144] This comparative example provides a method for purifying recombinant collagen, comprising the following steps:
[0145] 1) Flush the column with equilibration buffer at a linear flow rate of 60 cm / h (20 mL / min) for 1-2 CV until the pH, UV, and Cond detection baselines are stable and consistent with the equilibration buffer.
[0146] 2) The sample was loaded at a speed of 60 cm / h, and the flow-through components during the loading process were collected and the purity and content of the target protein were detected.
[0147] 3) After loading, rinse with equilibrium buffer at a speed of 60 cm / h for 3CV to wash out unbound materials until the UV detection value drops to the initial value.
[0148] 4) The elution buffer and the equilibration buffer were eluted at a speed of 60 cm / h according to a gradient of 100%-0% equilibration buffer for 5CV, and the eluate was collected.
[0149] 5) Wash the column with at least 2 column volumes of 1 M NaOH at a speed of 60 cm / h to remove residual contaminants in the packed column, such as lipids, endotoxins, nucleic acids, etc.;
[0150] 6) Wash the column with 5-10 CV of distilled water at a rate of 60 cm / h until the pH of the effluent is neutral and Cond is close to 0 to remove 1 M NaOH;
[0151] 7) Wash with 3CV of 20% ethanol to prevent microbial growth.
[0152] In step 2) of the comparative method, no sample pretreatment was added, and no balancing solution was used to dilute the sample, which affected the stability of the sample during the purification process. In step 4) of the comparative method, the elution buffer and the balancing buffer were eluted at a speed of 60 cm / h according to a 100%-0% balancing buffer gradient for 5CV, and the eluate was collected. In the present invention, a fixed ratio of elution buffer and balancing buffer was used, each eluted for 2CV, and the flow rate was increased to 90 cm / h. The elution method of the present invention has a better elution effect and obtains a higher protein purity.
[0153] In summary, the present invention constructs a Pichia pastoris strain that can stably and highly express recombinant collagen. The strain expresses recombinant collagen more stably and with higher purity, providing a research basis and a new approach for improving the expression and stability of recombinant collagen in Pichia pastoris.
[0154] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.
Claims
1. A Pichia pastoris strain capable of stably expressing recombinant collagen, It is characterized in that The strain uses the Pichia pastoris strain as a starting strain, expresses a recombinant collagen coding gene, and knocks out the gene YPS1 of the secretory protein degradation enzyme in the Pichia pastoris.
2. The Pichia pastoris strain capable of stably expressing recombinant collagen according to claim 1, It is characterized in that The Pichia pastoris strain is Pichia pastoris strain GS115.
3. The Pichia pastoris strain capable of stably expressing recombinant collagen according to claim 1 or 2, It is characterized in that The recombinant collagen encoding gene includes that shown in SEQ ID NO.1; Preferably, the recombinant collagen encoding gene is expressed in the form of plasmid or chromosomal integration.
4. The Pichia pastoris strain capable of stably expressing recombinant collagen according to any one of claims 1 to 3, It is characterized in that The method for knocking out the gene YPS1 of secretory protein degrading enzyme in Pichia pastoris comprises: The CRISPR / Cas9 gene editing method was used to construct a YPS1 gene editing vector targeting the target sequence of the YPS1 gene, and the YPS1 gene editing vector was transformed into a Pichia pastoris expression strain containing a recombinant collagen encoding gene to knock out the YPS1 gene in the strain; Preferably, the YPS1 gene editing vector comprises: gRNA and hsCas9; Preferably, the site targeted by the gRNA is the YPS1 gene; the DNA sequence corresponding to the gRNA includes those shown in SEQ ID NO.3 and SEQ ID NO.
4.
5. A YPS1 gene editing vector, It is characterized in that The vector includes: gRNA and hsCas9; the site targeted by the gRNA is the YPS1 gene; the DNA sequence corresponding to the gRNA includes those shown in SEQ ID NO.3 and SEQ ID NO.
4.
6. A vector for expressing recombinant collagen, It is characterized in that The vector includes a recombinant collagen encoding gene.
7. A method for stably expressing recombinant collagen, It is characterized in that The method comprises: The Pichia pastoris strain capable of stably expressing recombinant collagen described in any one of claims 1 to 4 is used for fermentation, and the fermentation product is purified by a four-step hydrophobic chromatography method to obtain pure collagen.
8. The method for stably expressing recombinant collagen according to claim 7, It is characterized in that The four-step purification of the hydrophobic chromatography comprises the following steps: (1) Equilibration: flush the column with the equilibration solution at a linear flow rate until the pH, UV, and Cond detection baselines are stable and consistent with the equilibration buffer; (2) Sampling: Loading the sample and collecting the flow-through components during the loading process; after the loading is completed, flushing with equilibrium buffer to wash out the unbound materials until the UV detection value drops to the initial value; (3) Washing: Use elution buffer and equilibration buffer to wash and remove impurities with weak binding force; (4) Elution: Use elution buffer and equilibration buffer to elute the target protein and collect the eluted fractions.
9. The method for stably expressing recombinant collagen according to claim 8, It is characterized in that In step (1), the equilibrium solution comprises, by concentration, 19-20 mM PB, 0.9-1 M ammonium sulfate, pH 7.9-8.0; Preferably, in step (1), the linear flow rate is 20-30 mL / min, and the amount of the equilibrium solution is 2.5-3.5 times the column volume; Preferably, in step (2), the sample loading volume is 1.25-1.5 column volumes; the sample loading flow rate is 20-30 mL / min; Preferably, in step (2), the sample loaded is a mixture of equal volumes of fermentation broth supernatant and equilibration buffer; Preferably, in step (2), the flushing flow rate is 20-30 mL / min, and the amount of the equilibration buffer is 2-3 times the column volume; Preferably, in step (3), the volume ratio of the elution buffer to the equilibration buffer is (3-3.5):(6.5-7); Preferably, the elution buffer comprises, by concentration: 19-20 mM PB, pH 7.9-8.0; Preferably, in step (3), the flow rate of the washing is 20-30 mL / min; Preferably, in step (4), the volume ratio of the elution buffer to the equilibration buffer is (6-6.5):(3.5-4); Preferably, in step (4), the elution flow rate is 20-30 mL / min.
10. Use of the Pichia pastoris strain capable of stably expressing recombinant collagen according to any one of claims 1 to 4, the YPS1 gene editing vector according to claim 5, the vector for expressing recombinant collagen according to claim 6, or the method capable of stably expressing recombinant collagen according to any one of claims 7 to 9 in the preparation of recombinant collagen.
Citation Information
Patent Citations
Recombinant human collagen and its coding gene and preparation method thereof
CN106554410A
Recombinant human collagen peptide and application thereof
CN111944057A
Pichia pastoris capable of efficiently secreting and expressing recombinant human III type collagen alpha1 chain and fermentation process of pichia pastoris
CN115029353A
Polynucleotides encoding bacterial collagen-like proteins
CN117957242A
Yeast mutant strains deficient in the multiple yapsingenes and method for the production of recombinantproteins using the same
KR1020040062304A
Cited By
Construction method and application of pichia pastoris strain capable of efficiently secreting and expressing recombinant human protein
CN119776172A
Method for efficiently integrating target genes into pichia pastoris genome in multiple copies
CN120041482A
Preparation method and application of recombinant human fibronectin
CN120424194A
